drugset / Trial / NCT07221877
A Study to Evaluate the Effect of KarXT on Urological Safety
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to characterize the effect of KarXT on voiding dynamics and urological safety in participants with DSM-5 schizophrenia.
Timeline
- Start
- 2026-01-20
- Primary completion
- 2027-12-30
- Completion
- 2027-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Trospium | Small molecule | — | — |
| Subject | Xanomeline | Small molecule | — | — |